Skip to main content
. 2014 Nov 5;3(6):e001285. doi: 10.1161/JAHA.114.001285

Table 1.

Baseline Demographic Characteristics and Correlations With Left Ventricular (LV) Mass/Body Surface Area (BSA) (n=905)

Mean (SD) or Proportion LV Mass/BSA
Characteristics Correlation (95% CI)*
Age, y 50.5 (6.6) 0.15 (0.08, 0.21)*
Body weight, kg 80.6 (11.3) 0.15 (0.09, 0.22)*
Body mass index, kg/m2 26.7 (3.1) 0.14 (0.08, 0.21)*
BSA, m2 1.94 (0.15) 0.14 (0.07, 0.20)*
Cigarette pack‐years of smoking* 7.6 (15.7) −0.04 (−0.10, 0.03)
Systolic blood pressure, mm Hg 132.3 (15.4) 0.14 (0.07, 0.20)*
Diastolic blood pressure, mm Hg 88.7 (10.2) 0.07 (0.01, 0.14)*
Serum total cholesterol, mmol/L 5.78 (1.00) −0.01 (−0.07, 0.06)
Serum LDL‐cholesterol, mmol/L 3.87 (0.92) −0.03 (−0.10, 0.03)
Serum HDL‐cholesterol, mmol/L 1.27 (0.29) 0.09 (0.02, 0.15)*
Cardiorespiratory fitness, mL/kg per minute* 32.1 (7.8) 0.04 (−0.03, 0.10)
Categorical variable Change relative to ref category*
Smoker, % 31.2 −2.22 (−5.78, 1.34)
Diabetes, %* 4.9 2.56 (−5.34, 10.45)
Atrial fibrillation, % 1.2 4.45 (−7.44, 16.33)
Hypertension, % 25.8 2.77 (−0.55, 6.09)
Family history of coronary heart disease, % 48.9 −1.42 (−4.74, 1.89)
Regular use of medication
Antihypertensive drugs, % 13.9 9.95 (5.56, 14.35)*
Statins,% 6.2 −5.94 (−26.39, 14.52)
β‐Blockers, % 9.6 7.68 (2.75, 12.62)*
Aspirin, % 9.5 −1.29 (−6.68, 4.11)

HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein.

*

P<0.05 for statistical significance.

*

Correlation coefficient (95% CI).

*

Pack‐years denotes the lifelong exposure to smoking which was estimated as the product of years smoked and the number of tobacco products smoked daily at the time of examination.

*

Cardiorespiratory fitness was defined as the highest value or the plateau of oxygen uptake during the exercise testing.

*

Reference is the category without the characteristic (eg, change relative to the reference).

*

Diabetes was defined as fasting blood glucose ≥6.1 mmol/L or a clinical diagnosis of diabetes with either dietary, oral, or insulin treatment.